Nureca Share Price

NSE
NURECA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Nureca Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
28.14% Fall from 52W High
19.8
TTM PE Ratio
High in industry
585.9
Price to Book Ratio
Below industry Median
1.7
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
5.2

Nureca Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Revenue
QuarterlyYearly
Jun 2024 - 20.269 Cr Mar 2024 - 102.442 Cr
Mar 2024 - 16.97 Cr Mar 2023 - 118.428 Cr
Dec 2023 - 22.374 Cr Mar 2022 - 263.243 Cr
Sep 2023 - 31.353 Cr Mar 2021 - 216.271 Cr
Jun 2023 - 21.231 Cr Mar 2020 - 101.78722 Cr
Net Profit/Loss
QuarterlyYearly
Jun 2024 - 1.662 Cr Mar 2024 - -1.794 Cr
Mar 2024 - -4.146 Cr Mar 2023 - -8.25 Cr
Dec 2023 - 0.165 Cr Mar 2022 - 44.96 Cr
Sep 2023 - 2.894 Cr Mar 2021 - 46.374 Cr
Jun 2023 - -0.707 Cr Mar 2020 - 6.4102 Cr

Nureca Ltd shareholding Pattern

Promoter
63.2%
Foreign Institutions
0.1%
Public
36.6%
Promoter
63.2%
Foreign Institutions
0.1%
Public
36.7%
Promoter
63.2%
Foreign Institutions
0.1%
Public
36.7%
Promoter
63.2%
Foreign Institutions
0.1%
Public
36.6%
Promoter
63%
Foreign Institutions
0.1%
Public
36.9%
Promoter
63%
Foreign Institutions
0.1%
Public
36.9%
Mutual Funds
1.4%
Mutual Funds
1.4%

Nureca Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
333.40
10Day EMA
327.10
12Day EMA
324.20
20Day EMA
314.00
26Day EMA
308.10
50Day EMA
295.60
100Day EMA
293.30
200Day EMA
314.20
5Day SMA
335.80
10Day SMA
327.50
20Day SMA
310.80
30Day SMA
295.60
50Day SMA
286.20
100Day SMA
280.40
150Day SMA
291.80
200Day SMA
316.00
Delivery & Volume
Day
Combined Delivery Volume- 35592 Rs
NSE+BSE Traded Volume- 61030 Rs

Week
Combined Delivery Volume- 38372 Rs
NSE+BSE Traded Volume- 81884 Rs

Month
Combined Delivery Volume- 55136 Rs
NSE+BSE Traded Volume- 137314 Rs

Resistance & Support
335.47
Pivot
Resistance
First Resistance
345.83
Second Resistance
354.77
Third Resistance
365.13
Support
First Support
326.53
Second support
316.17
Third Support
307.23
Relative Strength Index
66.29
Money Flow Index
77.49
MACD
16.10
MACD Signal
14.19
Average True Range
15.38
Average Directional Index
41.02
Rate of Change (21)
28.98
Rate of Change (125)
8.54

Nureca Ltd Company background

Founded in: 2016
Managing director: Saurabh Goyal
The Company was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. The Company is engaged in the business of home healthcare and wellness products. The Company is a leading healthcare and wellness company with a product range of over 150 SKUs across different categories. The flagship brands such as Dr. Trust continue to enjoy high credibility and a loyal customer base. The products comply with USFDA, European CE, ROHS and ISO certifications, which reinforce customers belief in their products. At present, the Company holds more than 100 design products. Nureca is a digital first, B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart, Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions, helping users monitor chronic ailments. The Company is committed to creating products that support diagnosis, treatment and prevention of illness through monitoring and analysis of health data. Nurecas products are manufactured to be safe, accurate, longlasting, and compliant with national and international regulations. The Companys growing range of connected devices is well entrenched in IoT and easy to sync with smart devices, while health app provides secure consolidation of data.The Company is focused on leveraging its innovation, research, and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives. The Company envisaged digital ecosystem and principles aims to provide integrated solutions aiding customers to maintain a suitable fitness regime, have clear understanding of and control over existing diseaseswith easier health monitoring at home and optimum nutrition through quality nutraceuticals.In 2017, the Company commenced business operations and launched Dr. Trust brand through digital healthcare channel.In 2018, the Company widened product basket with launching of brands in electric massages and mother child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab, Karnataka and Uttar Pradesh. In 2019, the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh, Telangana and Maharashtra. The Companys key products secured a warehouse drug license.In 2020, Company expanded presence through different channels and took initiative for starting business with 1mg, Pharmeasy, Paytm, and Croma retail stores. The Company had taken the effect of demerger as per the Scheme of Arrangement among Nectar Biopharma Private Limited (demerged company) and Nureca Private Limited (resulting company) and their respective shareholders and creditors under Section 230 to 232 and other applicable provisions of the Companies Act 2013, which has been sanctioned by the Honorable National Company Law Tribunal (NCLT), Mumbai vide its Order dated 29 April 2020. The Scheme had become effective on 23 May 2020 (Effective date) on filing of certified copy of the Order with the Registrar of Companies. The Appointed Date from which the Scheme was operative was 1 April 2019. Pursuant to the Scheme of Demerger, certain portion of business activities of the demerged company was transferred by Nectar Biopharma Private Limited from the Appointed date of 1 April 2019.In FY 2021, the Company received prestigious Economic Times Best Healthcare Brands Award 2021.
Read More

Nureca Ltd FAQs

Nureca Ltd shares are currently priced at 336.9 on NSE and 336.5 on BSE as of 9/12/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Nureca Ltd [NURECA] share was -6.57. The Nureca Ltd [NURECA] share hit a 1-year low of Rs. 240 and a 1-year high of Rs. 468.8.

The market cap of Nureca Ltd is Rs. 336.91 Cr. as of 9/12/2024 12:00:00 AM.

The PE ratios of Nureca Ltd is 0 as of 9/12/2024 12:00:00 AM.

The PB ratios of Nureca Ltd is 1.74 as of 9/12/2024 12:00:00 AM

You can easily buy Nureca Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -